
- November 2021
- Volume 87
- Issue 11
Generic Product News November 2021
Mycophenolate Mofetil for Oral Suspension
Marketed by Lannett
Compare To: CellCept
Lannett’s mycophenolate mofetil for oral suspension 200 mg/mL has received first-cycle approval from the FDA. It is equivalent to CellCept oral suspension 200 mg/mL. The oral suspension helps prevent organ rejection in allogeneic heart, kidney, or liver transplant recipients, according to a company statement. It is to be used with other immune suppressants and is a new dosage for Lannett. It can be prescribed for individuals 3 months and older.
FOR MORE INFORMATION:
lannett.com
Deferasirox Tablets
Marketed by Camber Pharmaceuticals
Compare to: Jadenu
Camber Pharmaceuticals has added deferasirox tablets, the generic equivalent of Jadenu, to its lineup. Deferasirox is used to treat iron overload caused by blood transfusions and chronic iron overload syndrome caused by a genetic blood disorder. The tablets come in 90-mg, 180-mg, and 360-mg dosages in 30-count bottles. It has been approved for use in individuals 2 years or older who have iron overload caused by blood transfusion and for individuals 10 years or older with chronic iron overload syndrome.
FOR MORE INFORMATION:
camberpharma.com
Carbamazepine Tablets
Marketed by VGYAAN
Compare to: Tegretol
The FDA has approved carbamazepine tablets 200 mg
from VGYAAN Pharmaceuticals. The medication is for use in individuals with partial, generalized, tonic-clonic, and mixed seizures, and trigeminal and glossopharyngeal neuralgia nerve pain, according to a company statement. It is the generic equivalent of Tegretol 200 mg.
FOR MORE INFORMATION:
vgyaan.com
Reddy-Lenalidomide
Marketed by Dr. Reddy’s
Compare to: Revlimid
Reddy-Lenalidomide, a generic equivalent to Revlimid, has been approved by Health Canada, according to a statement from Dr. Reddy’s Laboratories. The medication is used
to treat individuals with transfusion-dependent anemia because of low or intermediate 1-risk myelodysplastic syndromes from a deletion 5q cytogenetic abnormality with or without cytogenetic abnormalities. It is available in 2.5-mg, 5-mg, 10-mg, 15-mg, 20-mg, and 25-mg strength capsules in blister packs.
FOR MORE INFORMATION:
drreddys.com
Articles in this issue
almost 4 years ago
Medical Billing Is Now Part of Job Descriptionalmost 4 years ago
November 2021 Rx Product Newsalmost 4 years ago
Pharmacists Play Critical Role in Pain Assessmentalmost 4 years ago
Pet Peeves: November 2021almost 4 years ago
Ability to Produce Immunity to Influenza A (H3N2) Called Into Questionalmost 4 years ago
Consider a Career Move to Remote Medication Therapy Managementalmost 4 years ago
Nevada Board Stuns Nonresident Pharmacists With New Requirementsalmost 4 years ago
OTC Case Studies: Back PainNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.